Literature DB >> 20430419

Evaluation of the predictive value of ICD-9-CM coded administrative data for venous thromboembolism in the United States.

Richard H White1, Martina Garcia, Banafsheh Sadeghi, Daniel J Tancredi, Patricia Zrelak, Joanne Cuny, Pradeep Sama, Harriet Gammon, Stephen Schmaltz, Patrick S Romano.   

Abstract

OBJECTIVE: To determine the positive predictive value of International Classification of Disease, 9th Revision, Clinical Modification (ICD-9-CM) discharge codes for acute deep vein thrombosis or pulmonary embolism.
MATERIALS AND METHODS: Retrospective review of 3456 cases hospitalized between 2005 and 2007 that had a discharge code for venous thromboembolism, using 3 sample populations: a single academic hospital, 33 University HealthSystem Consortium hospitals, and 35 community hospitals in a national Joint Commission study. Analysis was stratified by position of the code in the principal versus a secondary position.
RESULTS: Among 1096 cases that had a thromboembolism code in the principal position the positive predictive value for any acute venous thrombosis was 95% (95%CI:93-97), whereas among 2360 cases that had a thromboembolism code in a secondary position the predictive value was lower, 75% (95%CI:71-80). The corresponding positive predictive values for lower extremity deep-vein thrombosis or pulmonary embolism were 91% (95%CI:86-95) and 50% (95%CI:41-58), respectively. More highly defined codes had higher predictive value. Among codes in a secondary position that were false positive, 22% (95%CI:16-27) had chronic/prior venous thrombosis, 15% (95%CI:10-19) had an upper extremity thrombosis, 6% (95%CI:4-8) had a superficial vein thrombosis, and 7% (95%CI:4-13) had no mention of any thrombosis.
CONCLUSIONS: ICD-9-CM codes for venous thromboembolism had high predictive value when present in the principal position, and lower predictive value when in a secondary position. New thromboembolism codes that were added in 2009 that specify chronic thrombosis, upper extremity thrombosis and superficial venous thrombosis should reduce the frequency of false-positive thromboembolism codes. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20430419     DOI: 10.1016/j.thromres.2010.03.009

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  88 in total

1.  Clinical outcomes and costs associated with procalcitonin utilization in hospitalized patients with pneumonia, heart failure, viral respiratory infection, or chronic obstructive pulmonary disease.

Authors:  Stacy Aric Johnson; Austin Bernard Rupp; Kirsten Leigh Rupp; Santosh Reddy
Journal:  Intern Emerg Med       Date:  2021-01-16       Impact factor: 3.397

2.  Using multiple sources of data for surveillance of postoperative venous thromboembolism among surgical patients treated in Department of Veterans Affairs hospitals, 2005-2010.

Authors:  Richard E Nelson; Scott D Grosse; Norman J Waitzman; Junji Lin; Scott L DuVall; Olga Patterson; James Tsai; Nimia Reyes
Journal:  Thromb Res       Date:  2015-01-26       Impact factor: 3.944

3.  High-throughput multimodal automated phenotyping (MAP) with application to PheWAS.

Authors:  Katherine P Liao; Jiehuan Sun; Tianrun A Cai; Nicholas Link; Chuan Hong; Jie Huang; Jennifer E Huffman; Jessica Gronsbell; Yichi Zhang; Yuk-Lam Ho; Victor Castro; Vivian Gainer; Shawn N Murphy; Christopher J O'Donnell; J Michael Gaziano; Kelly Cho; Peter Szolovits; Isaac S Kohane; Sheng Yu; Tianxi Cai
Journal:  J Am Med Inform Assoc       Date:  2019-11-01       Impact factor: 4.497

4.  Effectiveness and safety of rivaroxaban versus warfarin in patients with provoked venous thromboembolism.

Authors:  Craig I Coleman; Alexander G G Turpie; Thomas J Bunz; Jan Beyer-Westendorf
Journal:  J Thromb Thrombolysis       Date:  2018-10       Impact factor: 2.300

5.  Design and Implementation of a Comprehensive Surveillance System for Venous Thromboembolism in a Defined Region Using Electronic and Manual Approaches.

Authors:  Thomas L Ortel; Katie Arnold; Michele Beckman; Audrey Brown; Nimia Reyes; Ibrahim Saber; Ryan Schulteis; Bhavana Pendurthi Singh; Andrea Sitlinger; Elizabeth H Thames
Journal:  Appl Clin Inform       Date:  2019-07-31       Impact factor: 2.342

6.  Comparative Safety and Effectiveness of Direct-Acting Oral Anticoagulants Versus Warfarin: a National Cohort Study of Nursing Home Residents.

Authors:  Matthew Alcusky; Jennifer Tjia; David D McManus; Anne L Hume; Marc Fisher; Kate L Lapane
Journal:  J Gen Intern Med       Date:  2020-04-06       Impact factor: 5.128

7.  The design and implementation of a new surveillance system for venous thromboembolism using combined active and passive methods.

Authors:  Aaron M Wendelboe; Janis Campbell; Micah McCumber; Dale Bratzler; Kai Ding; Michele Beckman; Nimia Reyes; Gary Raskob
Journal:  Am Heart J       Date:  2015-06-11       Impact factor: 4.749

8.  National and Regional Trends in Deep Vein Thrombosis Hospitalization Rates, Discharge Disposition, and Outcomes for Medicare Beneficiaries.

Authors:  Karl E Minges; Behnood Bikdeli; Yun Wang; Robert R Attaran; Harlan M Krumholz
Journal:  Am J Med       Date:  2018-06-23       Impact factor: 4.965

9.  Healthcare burden of venous thromboembolism in childhood chronic renal diseases.

Authors:  Bryce A Kerlin; William E Smoyer; James Tsai; Sheree L Boulet
Journal:  Pediatr Nephrol       Date:  2014-12-07       Impact factor: 3.714

10.  Risk of venous thromboembolism among hospitalizations of adults with selected autoimmune diseases.

Authors:  Hussain R Yusuf; W Craig Hooper; Michele G Beckman; Qing C Zhang; James Tsai; Thomas L Ortel
Journal:  J Thromb Thrombolysis       Date:  2014-10       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.